214 | FINAL INDEPENDENT REVIEW DATA SUPPORTS SUSTAINED BENEFIT OF ZANUBRUTINIB OVER IBRUTINIB IN PATIENTS WITH R/R CLL/SLL IN ALPINE

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	J. R. Brown, S. M. O’Brien, B. F. Eichhorst, N. Lamanna, C. S. Tam, L. Qiu, W. Jurczak, K. Zhou, M. Šimkovič, A. Panovská, A. Gillespie‐Twardy, A. Ferrajoli, P. S. Ganly, R. Weinkove, S. Grosicki, A. Mital, T. Robak, A. Österborg, H. A. Yimer, M. Wang, K. Wu, T. Salmi, M. Shadman
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet